A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 322
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : VCM
Long Form : vancomycin
No. Year Title Co-occurring Abbreviation
2020 A New Algorithm Optimized for Initial Dose Settings of Vancomycin Using Machine Learning. DT, ML, TDM
2020 AB2-type amphiphilic block copolymer containing a pH-cleavable hydrazone linkage for targeted antibiotic delivery. MRSA, S. aureus
2020 Association of mprF mutations with cross-resistance to daptomycin and vancomycin in methicillin-resistant Staphylococcus aureus (MRSA). CW, DAP, DAPS, L-PG, MRSA, VISA
2020 Association of the ward pharmacy service with active implementation of therapeutic drug monitoring for vancomycin and teicoplanin-an epidemiological surveillance study using Japanese large health insurance claims database. ABK, MRSA, TDM, TEIC
2020 Chlorogenic acid prevents vancomycin-induced nephrotoxicity without compromising vancomycin antibacterial properties. CA
2020 Clostridioides (Clostridium) difficile infection in Japanese hospitals 2008-2017: A real-world nationwide analysis of treatment pattern, incidence and testing density. CDI, DPC, EIA, MNZ
2020 Comparing the release of erythromycin and vancomycin from calcium polyphosphate hydrogel using different drug loading methods. CPP, EM
2020 Comparison of breakthrough Gram-positive cocci infection during vancomycin vs teicoplanin therapy in patients receiving haematopoietic stem cell transplantation. DAP, FN, GPC, HSCT, MR-S haemolyticus, TEIC
2020 Concomitant vancomycin and piperacillin/tazobactam treatment is associated with an increased risk of acute kidney injury in Japanese patients. AKI, PT
10  2020 Development and validation of LC-MS/MS methods to measure tobramycin and lincomycin in plasma, microdialysis fluid and urine: application to a pilot pharmacokinetic research study. LMC, TMC
11  2020 Fidaxomicin compared with vancomycin and metronidazole for the treatment of Clostridioides (Clostridium) difficile infection: A network meta-analysis. CrI, FDX, MTZ, NMA, OR, RCTs
12  2020 Injectable Chitosan-Based Thermosensitive Hydrogel/Nanoparticle-Loaded System for Local Delivery of Vancomycin in the Treatment of Osteomyelitis. CS
13  2020 Pediatric pharmaceutical care with anti-infective medication in a patient with acute hematogenous osteomyelitis caused by methicillin-resistant Staphylococcus aureus. MRSA
14  2020 pH-Responsive Micelles from an Oleic Acid Tail and Propionic Acid Heads Dendritic Amphiphile for the Delivery of Antibiotics. CMC, MIC, MRSA, OLA-SPDA, PDI, ZP
15  2020 Potential protective effects of naringenin against vancomycin-induced nephrotoxicity via reduction on apoptotic and oxidative stress markers in rats. BUN, i.p, MDA, NAR, NO
16  2020 Protection of gut microbiome from antibiotics: development of a vancomycin-specific adsorbent with high adsorption capacity. AC, MPs
17  2020 Purpuric drug eruption without leukocytoclastic vasculitis associated with vancomycin. ---
18  2020 Pyramid-Shaped PEG-PCL-PEG Polymeric-Based Model Systems for Site-Specific Drug Delivery of Vancomycin with Enhance Antibacterial Efficacy. MRSA, PCL, PEG
19  2020 Successful Vancomycin Dose Adjustment in a Sepsis patient with Bacterial Meningitis Using Cystatin C. TDM
20  2020 Supramolecular self-assembled drug delivery system (SADDs) of vancomycin and tocopherol succinate as an antibacterial agent: invitro, in silico and invivo evaluations. MIC, MRSA, SA, SADDs, TS
21  2020 The combination of silver-containing hydroxyapatite coating and vancomycin has a synergistic antibacterial effect on methicillin-resistant Staphylococcus aureus biofilm formation. CFUs, HA, MRSA, PJI, Ti discs
22  2020 The physiological and toxicological effects of antibiotics on an interspecies insect model. CAM
23  2020 The Trend for Antibiotic Use for Clostridioides (Clostridium) difficile Infection in Japan. CPGs, MNZ
24  2020 Toxicity Profile and Pharmacokinetic Study of Antibiotic Mixtures, Gentamicin and Vancomycin, in Rat Plasma by Ecofriendly Liquid Chromatography Coupled Tandem Mass Spectrometry. ACN, AMK, GTM, MRM, MRSA
25  2020 Vancomycin pharmacokinetics in critically ill patients receiving continuous haemodiafiltration with a polyethyleneimine-coated polyacrylonitrile membrane. CHDF, PK
26  2020 Vancomycin-loaded nanoparticles against vancomycin intermediate and methicillin resistant Staphylococcus aureus strains. HTF, MRSA, NP, VISA, VNp
27  2020 Zingerone attenuates vancomycin-induced hepatotoxicity in rats through regulation of oxidative stress, inflammation and apoptosis. Bax, Bcl-2, BW, caspase-3, caspase-8, COX-2, IL-1beta, iNOS, NF-kappaB, TNF-alpha, Zin
28  2019 Construction of a risk prediction model of vancomycin-associated nephrotoxicity to be used at the time of initial therapeutic drug monitoring: A data mining analysis using a decision tree model. DT, TDM
29  2019 Correlation between vancomycin penetration into cerebrospinal fluid and protein concentration in cerebrospinal fluid/serum albumin ratio. BBB, CSF
30  2019 Delivery of novel vancomycin nanoplexes for combating methicillin resistant Staphylococcus aureus (MRSA) infections. DXT, MIC, MRSA, PDI, ZP
31  2019 Development of a novel assay of molecularly imprinted membrane by design-based gaussian pattern for vancomycin determination. MIM, PVDF
32  2019 Drug-induced linear immunoglobulin A bullous dermatosis: A French retrospective pharmacovigilance study of 69 cases. IgA, TEN
33  2019 Effect of serum concentration and concomitant drugs on vancomycin-induced acute kidney injury in haematologic patients: a single-centre retrospective study. AKI, KDIGO, L-AmB, TAZ/PIPC
34  2019 Efficacy of Azithromycin in a Mouse Pneumonia Model against Hospital-Acquired Methicillin-Resistant Staphylococcus aureus. AZM, DAP, IL-6, MIP-2, MRSA, SPA
35  2019 Evaluation for optimal dosing of vancomycin in patients with different physical types. BMI
36  2019 Higher incidence of acute kidney injury in patients treated with piperacillin/tazobactam than in patients treated with cefepime: a single-center retrospective cohort study. AKI, CFPM, CI, OR, PIPC/TAZ
37  2019 Infectious Keratitis: Microbiological Review of 297 Cases. GM, TO
38  2019 Linezolid Consumption Facilitates the Development of Linezolid Resistance in Enterococcus faecalis in a Tertiary-Care Hospital: A 5-Year Surveillance Study. DBD, DDDs, LNSEF, LZD
39  2019 Liposomes with pH responsive 'on and off' switches for targeted and intracellular delivery of antibiotics. POPC
40  2019 pH-Responsive Lipid-Dendrimer Hybrid Nanoparticles: An Approach To Target and Eliminate Intracellular Pathogens. LDH-NPs, MD, MRSA, vdW
41  2019 Population Pharmacokinetics of Vancomycin under Continuous Renal Replacement Therapy using a Polymethylmethacrylate Hemofilter. BW, CHDF, SOFA
42  2019 Relationship between hemoglobin levels and vancomycin clearance in patients with sepsis. ---
43  2019 Risk factors for vancomycin nephrotoxicity and time course of renal function during vancomycin treatment. ---
44  2019 Rutin Attenuates Vancomycin-Induced Nephrotoxicity by Ameliorating Oxidative Stress, Apoptosis, and Inflammation in Rats. ---
45  2019 Self-assembled oleylamine grafted hyaluronic acid polymersomes for delivery of vancomycin against methicillin resistant Staphylococcus aureus (MRSA). HA-OLA, MIC, MRSA
46  2019 Simultaneous determination of vancomycin and creatinine in plasma applied to volumetric absorptive microsampling devices using liquid chromatography-tandem mass spectrometry. CRE, VAMS
47  2019 The effects of zingerone against vancomycin-induced lung, liver, kidney and testis toxicity in rats: The behavior of some metabolic enzymes. ZO
48  2018 A double-blind randomized controlled trial of the local application of vancomycin versus ampicillin powder into the operative field for thoracic and/or lumbar fusions. AMP, SSI
49  2018 A hybrid of mPEG-b-PCL and G1-PEA dendrimer for enhancing delivery of antibiotics. HSA, MD, MIC, MRSA, MST
50  2018 Brain Microdialysis Study of Vancomycin in the Cerebrospinal Fluid After Intracerebroventricular Administration in Mice. CSF, i.c.v, i.v, MRSA
51  2018 Calcium Phosphate Cement loaded with 10% vancomycin delivering high early and late local antibiotic concentration in vitro. CPC
52  2018 Conductive vancomycin-loaded mesoporous silica polypyrrole-based scaffolds for bone regeneration. HAP, PPy
53  2018 Contribution of pharmacists with expertise in infectious diseases to appropriate individualized vancomycin dosing. ---
54  2018 Double-layered antibiotic-loaded cement spacer as a novel alternative for managing periprosthetic joint infection: an in vitro study. ---
55  2018 Fatty acid conjugated pyridinium cationic amphiphiles as antibacterial agents and self-assembling nano carriers. E. coli, FCA, MIC, MRSA, OCA, P. aeruginosa, TEM
56  2018 In Vivo Release of Vancomycin from Calcium Phosphate Cement. CPC, PMMA
57  2018 Novel lipids with three C18-fatty acid chains and an amino acid head group for pH-responsive and sustained antibiotic delivery. MICs, MRSA, PSLs
58  2018 Oral vancomycin versus metronidazole for the treatment of Clostridioides difficile infection: Meta-analysis of randomized controlled trials. CDI, MNZ
59  2018 Preliminary study on the effect of brazilin on biofilms of Staphylococcus aureus. BN, ica, QS
60  2018 Relationship Between Initial Vancomycin Trough Levels and Early-Onset Vancomycin-Associated Nephrotoxicity in Critically Ill Patients. ---
61  2018 Synthesis of an oleic acid based pH-responsive lipid and its application in nanodelivery of vancomycin. EE, NMEO, PDI, PS, ZP
62  2018 The trend of resistance to antibiotics for ocular infection of Staphylococcus aureus, coagulase-negative staphylococci, and Corynebacterium compared with 10-years previous: A retrospective observational study. ABK, CMX, CNS, CP, EM, LVFX, MRCNS, MRSA
63  2018 Therapeutic efficacy of zingerone against vancomycin-induced oxidative stress, inflammation, apoptosis and aquaporin 1 permeability in rat kidney. AQP1, Bax, Bcl-3, caspase-3, CAT, COX-2, GPx, IL-1beta, IL-33, iNOS, MPO, NF-kappaB, PGE2, SOD, TNF-alpha, ZO
64  2018 Validation of a Nomogram for Achieving Target Trough Concentration of Vancomycin: Accuracy in Patients With Augmented Renal Function. ---
65  2018 Vancomycin Mediates IgA Autoreactivity inDrug-Induced Linear IgA BullousDermatosis. LAD
66  2018 [Effect of pH and Additives on the Compatibility between Vancomycin and Furosemide Injections]. ---
67  2017 A UPLC-MS/MS method for analysis of vancomycin in human cerebrospinal fluid and comparison with the chemiluminescence immunoassay. CLIA, CSF
68  2017 Determination of Vancomycin in Human Serum by Cyclodextrin-Micellar Electrokinetic Capillary Chromatography (CD-MEKC) and Application for PDAP Patients. CD-MEKC, LLOQ, PDAP, SDS, sulfobutyl-beta-CD
69  2017 Effects of Teicoplanin on the PT-INR Controlled by Warfarin in Infection Patients. PT-INR, TEIC, WF
70  2017 Increased drug resistance of meticillin-resistant Staphylococcus aureus biofilms formed on a mouse dermal chip model. MBC, MRSA, PC-BF, PCs
71  2017 Intrawound Vancomycin powder as the prophylaxis of surgical site infection after invasive spine surgery with a high risk of infection. SSIs
72  2017 Invivo serum concentration of vancomycin in antibiotic-loaded acrylic cement for the treatment and prevention of periprosthetic hip infection. ALAC, THA
73  2017 Linezolid versus vancomycin for nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus in the elderly: A retrospective cohort analysis: Effectiveness of linezolid in the elderly. LZD, MRSA, SOFA
74  2017 Studying the influence of formulation and process variables on Vancomycin-loaded polymeric nanoparticles as potential carrier for enhanced ophthalmic delivery. PNPs
75  2017 The Effects of Fasting and Massive Diarrhea on Absorption of Enteral Vancomycin in Critically Ill Patients: A Retrospective Observational Study. TDM
76  2017 Usefulness of a decision tree model for the analysis of adverse drug reactions: Evaluation of a risk prediction model of vancomycin-associated nephrotoxicity constructed using a data mining procedure. DT
77  2017 Validating the Effectiveness of Switching the Vancomycin TDM Analysis Software Based on the Predictive Accuracy. MEEK, TDM
78  2017 Vancomycin induces reactive oxygen species-dependent apoptosis via mitochondrial cardiolipin peroxidation in renal tubular epithelial cells. ---
79  2017 [Evaluation of Pharmacotherapy on Emergency and Intensive Care Medicine: The Influence of Intensity and Duration of Invasion]. PHT, SIRS, TDM
80  2016 A case report of bacteremia manifesting as an overwhelming postsplenectomy infection due to Streptococcus pneumoniae post vaccination. DRPM, OPSI, SBP
81  2016 Augmented Renal Clearance in Patients With Febrile Neutropenia is Associated With Increased Risk for Subtherapeutic Concentrations of Vancomycin. ARC, OR
82  2016 Augmented Renal Clearance in Pediatric Patients With Febrile Neutropenia Associated With Vancomycin Clearance. ARC, eGFR
83  2016 Baicalein Inhibits Staphylococcus aureus Biofilm Formation and the Quorum Sensing System In Vitro. Hla, RT-qPCR, SEA
84  2016 Clinical Evaluation of Pharmacist Interventions in Patients Treated with Anti-methicillin-Resistant Staphylococcus aureus Agents in a Hematological Ward. ABK, MRSA, TDM, TEIC
85  2016 Co-encapsulation of multi-lipids and polymers enhances the performance of vancomycin in lipid-polymer hybrid nanoparticles: In vitro and in silico studies. ALG, CHT, LPNs, OA
86  2016 Duration of Systemic Inflammatory Response Syndrome Influences Serum Vancomycin Concentration in Patients With Sepsis. CrCl, PPK, SIRS
87  2016 Impact of caffeic acid phenethyl ester treatment on vancomycin-induced pancreatic damage in rats. ALP, CAPE, GGT
88  2016 Improvement of Predictivity of Teicoplanin Serum Trough Concentrations at Steady State Calculated by Vancomycin Pharmacokinetic Parameter. CL, PPK, TEIC
89  2016 Nanoparticles as tool for enhanced ophthalmic delivery of vancomycin: a multidistrict-based microbiological study, solid lipid nanoparticles formulation and evaluation. PS, PVA, SLNs
90  2016 Occurrence, fate, and risk assessment of vancomycin in two typical pharmaceutical wastewater treatment plants in Eastern China. PWWTPs
91  2016 Pharmacist-managed dose adjustment feedback using therapeutic drug monitoring of vancomycin was useful for patients with methicillin-resistant Staphylococcus aureus infections: a single institution experience. ASP, MIC, MRSA, PD, PK
92  2016 Polyelectrolyte complex of vancomycin as a nanoantibiotic: Preparation, in vitro and in silico studies. PAA
93  2016 Population pharmacokinetics of vancomycin in adult Chinese patients with post-craniotomy meningitis and its application in individualised dosage regimens. PCM, PPK
94  2016 Therapeutic Drug Monitoring of Vancomycin in Dermal Interstitial Fluid Using Dissolving Microneedles. DMNs, ISF
95  2016 Vancomycin-induced linear IgA bullous dermatosis: associations. LABD
96  2016 [Preparation and Property Investigation of Vancomycin Loaded Calcium Sulfate Hemihydrate/Silk Fibroin Microsphere Artificial Bone Composites with Different Concentration]. C-S-H, FTIR, SEM, SFM
97  2016 [Therapeutic Drug Monitoring of Antimicrobial Agents]. PK, TDM
98  2015 An investigation into the vancomycin concentration in the cerebrospinal fluid due to vancomycin intraventricular administration in newborns: a study of 13 cases. CSF
99  2015 Biofilm-forming Staphylococcus epidermidis expressing vancomycin resistance early after adhesion to a metal surface. BCRs
100  2015 Clinical utility of antibiotic-loaded hydroxyapatite block for treatment of intractable periprosthetic joint infection and septic arthritis of the hip. AHAB, ALAC, PJI, SA